OPTN/SRTR 2019 Annual Data Report: Pancreas

R. Kandaswamy; P. G. Stock; J. Miller; M. A. Skeans; J. White; J. Wainright; N. T.T. Kyaw; S. Niederhaus; A. K. Israni; J. J. Snyder

doi:10.1111/ajt.16496

OPTN/SRTR 2019 Annual Data Report: Pancreas

R. Kandaswamy, P. G. Stock, J. Miller, M. A. Skeans, J. White, J. Wainright, N. T.T. Kyaw, S. Niederhaus, A. K. Israni, J. J. Snyder

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

The overall number of pancreas transplants decreased slightly, from 1027 in 2018 to 1015, in 2019, up from a nadir of 947 in 2015. However, the number of simultaneous pancreas-kidney transplants (SPKs) increased in 2019, with a corresponding drop in pancreas-after-kidney transplants (PAKs) and pancreas transplants alone (PTAs). New waitlist registrations increased to 1772 in 2019, from 1606 in 2018. This was predominately driven by SPK listings, and those with type 2 diabetes. Waiting time for SPK decreased by 2 months, to a median of 12 months in 2019, but PTA recipient mean waiting time remained substantially higher, at 24 months, in 2018. Both short- and long-term outcomes, including patient survival, kidney graft survival, and acute rejection-free graft survival, have shown consistent improvement over the last decade. Pancreas graft survival data with the uniform definition of allograft failure is being collected by the Organ Procurement and Transplant Network (OPTN) and will be included in a future report.

Original language	English (US)
Pages (from-to)	138-207
Number of pages	70
Journal	American Journal of Transplantation
Volume	21 Suppl 2
Issue number	S2
DOIs	https://doi.org/10.1111/ajt.16496
State	Published - Feb 2021

Bibliographical note

Publisher Copyright:
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

Keywords

Pancreas transplant
pancreas after kidney transplant
pancreas transplant alone
simultaneous kidney pancreas transplant
Pancreas Transplantation
Humans
Tissue and Organ Procurement
Graft Survival
Diabetes Mellitus, Type 2
Pancreas

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1111/ajt.16496

Find It

Find It at U of M Libraries

Cite this

@article{9cfa902295dc48558ff1c4ee4857ece3,

title = "OPTN/SRTR 2019 Annual Data Report: Pancreas",

abstract = "The overall number of pancreas transplants decreased slightly, from 1027 in 2018 to 1015, in 2019, up from a nadir of 947 in 2015. However, the number of simultaneous pancreas-kidney transplants (SPKs) increased in 2019, with a corresponding drop in pancreas-after-kidney transplants (PAKs) and pancreas transplants alone (PTAs). New waitlist registrations increased to 1772 in 2019, from 1606 in 2018. This was predominately driven by SPK listings, and those with type 2 diabetes. Waiting time for SPK decreased by 2 months, to a median of 12 months in 2019, but PTA recipient mean waiting time remained substantially higher, at 24 months, in 2018. Both short- and long-term outcomes, including patient survival, kidney graft survival, and acute rejection-free graft survival, have shown consistent improvement over the last decade. Pancreas graft survival data with the uniform definition of allograft failure is being collected by the Organ Procurement and Transplant Network (OPTN) and will be included in a future report.",

keywords = "Pancreas transplant, pancreas after kidney transplant, pancreas transplant alone, simultaneous kidney pancreas transplant, Pancreas Transplantation, Humans, Tissue and Organ Procurement, Graft Survival, Diabetes Mellitus, Type 2, Pancreas",

author = "R. Kandaswamy and Stock, {P. G.} and J. Miller and Skeans, {M. A.} and J. White and J. Wainright and Kyaw, {N. T.T.} and S. Niederhaus and Israni, {A. K.} and Snyder, {J. J.}",

note = "Publisher Copyright: {\textcopyright} 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.",

year = "2021",

month = feb,

doi = "10.1111/ajt.16496",

language = "English (US)",

volume = "21 Suppl 2",

pages = "138--207",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Wiley-Blackwell",

number = "S2",

}

TY - JOUR

T1 - OPTN/SRTR 2019 Annual Data Report

T2 - Pancreas

AU - Kandaswamy, R.

AU - Stock, P. G.

AU - Miller, J.

AU - Skeans, M. A.

AU - White, J.

AU - Wainright, J.

AU - Kyaw, N. T.T.

AU - Niederhaus, S.

AU - Israni, A. K.

AU - Snyder, J. J.

PY - 2021/2

Y1 - 2021/2

N2 - The overall number of pancreas transplants decreased slightly, from 1027 in 2018 to 1015, in 2019, up from a nadir of 947 in 2015. However, the number of simultaneous pancreas-kidney transplants (SPKs) increased in 2019, with a corresponding drop in pancreas-after-kidney transplants (PAKs) and pancreas transplants alone (PTAs). New waitlist registrations increased to 1772 in 2019, from 1606 in 2018. This was predominately driven by SPK listings, and those with type 2 diabetes. Waiting time for SPK decreased by 2 months, to a median of 12 months in 2019, but PTA recipient mean waiting time remained substantially higher, at 24 months, in 2018. Both short- and long-term outcomes, including patient survival, kidney graft survival, and acute rejection-free graft survival, have shown consistent improvement over the last decade. Pancreas graft survival data with the uniform definition of allograft failure is being collected by the Organ Procurement and Transplant Network (OPTN) and will be included in a future report.

AB - The overall number of pancreas transplants decreased slightly, from 1027 in 2018 to 1015, in 2019, up from a nadir of 947 in 2015. However, the number of simultaneous pancreas-kidney transplants (SPKs) increased in 2019, with a corresponding drop in pancreas-after-kidney transplants (PAKs) and pancreas transplants alone (PTAs). New waitlist registrations increased to 1772 in 2019, from 1606 in 2018. This was predominately driven by SPK listings, and those with type 2 diabetes. Waiting time for SPK decreased by 2 months, to a median of 12 months in 2019, but PTA recipient mean waiting time remained substantially higher, at 24 months, in 2018. Both short- and long-term outcomes, including patient survival, kidney graft survival, and acute rejection-free graft survival, have shown consistent improvement over the last decade. Pancreas graft survival data with the uniform definition of allograft failure is being collected by the Organ Procurement and Transplant Network (OPTN) and will be included in a future report.

KW - Pancreas transplant

KW - pancreas after kidney transplant

KW - pancreas transplant alone

KW - simultaneous kidney pancreas transplant

KW - Pancreas Transplantation

KW - Humans

KW - Tissue and Organ Procurement

KW - Graft Survival

KW - Diabetes Mellitus, Type 2

KW - Pancreas

UR - http://www.scopus.com/inward/record.url?scp=85101059148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101059148&partnerID=8YFLogxK

U2 - 10.1111/ajt.16496

DO - 10.1111/ajt.16496

M3 - Article

C2 - 33595197

AN - SCOPUS:85101059148

SN - 1600-6135

VL - 21 Suppl 2

SP - 138

EP - 207

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - S2

ER -

OPTN/SRTR 2019 Annual Data Report: Pancreas

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this